Concepedia

Elizabeth M. Gonzalez

EM

Statistics

Publications

16

Citations

566

H-Index

13

Active since

1988

Affiliations

Dana-Farber Cancer Institute(Current)

Broad Institute

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Harvard University

University Hospital Heidelberg

Elizabeth M. Gonzalez is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and oncogenes.

Publications per year

1988–2023

16

Publications

16

Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition

Ramadevi Subramani, Elizabeth M. Gonzalez, Arunkumar Arumugam et al. · Scientific Reports · 2016 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17

Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway

Ramadevi Subramani, Elizabeth M. Gonzalez, Sushmita Nandy et al. · Oncotarget · 2016 · 72 citations · Full text

Medicine, Oncology, Pharmacology +15

Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma

Pratiti Bandopadhayay, Federica Piccioni, Ryan O’Rourke et al. · Nature Communications · 2019 · 60 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation

Prasidda Khadka, Zachary J. Reitman, Sophie D. Lu et al. · Nature Communications · 2022 · 58 citations · Full text

Medicine, Molecular Genetics, Oncology +17

ADPedKD: A Global Online Platform on the Management of Children With ADPKD

Stéphanie De Rechter, Detlef Böckenhauer, Lisa M. Guay‐Woodford et al. · Kidney International Reports · 2019 · 26 citations · Full text

Medicine, Nephrology, Pediatrics +14

1–5 of 16